AU2002239417A1 - Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor - Google Patents

Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor

Info

Publication number
AU2002239417A1
AU2002239417A1 AU2002239417A AU3941702A AU2002239417A1 AU 2002239417 A1 AU2002239417 A1 AU 2002239417A1 AU 2002239417 A AU2002239417 A AU 2002239417A AU 3941702 A AU3941702 A AU 3941702A AU 2002239417 A1 AU2002239417 A1 AU 2002239417A1
Authority
AU
Australia
Prior art keywords
anaphylatoxin
diagnostic
receptor
therapeutic compositions
methods related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239417A
Inventor
Joseph P. Brown
Glenna C Burmer
Douglas A. Morningstar
Christine L. Roush
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeSpan BioSciences Inc
Original Assignee
LifeSpan BioSciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeSpan BioSciences Inc filed Critical LifeSpan BioSciences Inc
Publication of AU2002239417A1 publication Critical patent/AU2002239417A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2835Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Psychology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002239417A 2000-11-29 2001-11-29 Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor Abandoned AU2002239417A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US25025100P 2000-11-29 2000-11-29
US60/250,251 2000-11-29
US25045200P 2000-11-30 2000-11-30
US60/250,452 2000-11-30
US33003601P 2001-10-17 2001-10-17
US60/330,036 2001-10-17
PCT/US2001/045220 WO2002044737A2 (en) 2000-11-29 2001-11-29 Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor

Publications (1)

Publication Number Publication Date
AU2002239417A1 true AU2002239417A1 (en) 2002-06-11

Family

ID=27400298

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239417A Abandoned AU2002239417A1 (en) 2000-11-29 2001-11-29 Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor

Country Status (2)

Country Link
AU (1) AU2002239417A1 (en)
WO (1) WO2002044737A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002239417A1 (en) * 2000-11-29 2002-06-11 Lifespan Biosciences, Inc. Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor
WO2004082566A2 (en) * 2003-03-17 2004-09-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with complement component 3a receptor 1 (c3ar1)
EP1782072A2 (en) * 2004-04-15 2007-05-09 Reglia AB Materials and methods for screening modulators of neural regneration
JPWO2011071136A1 (en) 2009-12-11 2013-04-22 アステラス製薬株式会社 Fibromyalgia treatment
GB201619637D0 (en) * 2016-11-21 2017-01-04 Pekna Marcela And Pekny Milos And Stokowska Anna C3a receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1087700A (en) * 1996-06-17 1998-04-07 Smithkline Beecham Corp Treatment and screening using c3a receptor and c3a
US5989592A (en) * 1996-10-03 1999-11-23 Coastside Bio Resources Inhibition of complement pathway by sea cucumber fractions
JP2001517648A (en) * 1997-09-23 2001-10-09 スミスクライン・ビーチャム・コーポレイション C3A receptor ligand
AU2002239417A1 (en) * 2000-11-29 2002-06-11 Lifespan Biosciences, Inc. Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor

Also Published As

Publication number Publication date
WO2002044737A2 (en) 2002-06-06
WO2002044737A3 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
AU4835001A (en) Antibodies to human cd154
AU6118001A (en) Combination therapeutic compositions and methods of use
HK1061403A1 (en) ANTIBODIES TO HUMAN IL-1ß
HUP0500983A2 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
IL158107A0 (en) Human papillomaviruses vaccine
AU1328502A (en) Novel targeted compositions for diagnostic and therapeutic use
AU2001233081A1 (en) Composition for treatment of stress
EP1545599A4 (en) Immunogenic compositions and diagnostic and therapeutic uses thereof
AU2001279540A1 (en) Dental splint
GB0002386D0 (en) Therapeutic composition
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
HUP0301317A3 (en) Use of neuroprotective 7-beta-hydroxysteroids for preparation of pharmaceutical compositions
HUP0104963A3 (en) Compositions for the treatment of skin diseases
AU2001232866A1 (en) Skin care compositions
AU2002239417A1 (en) Diagnostic and therapeutic compositions and methods related to anaphylatoxin c3a receptor
GB9928535D0 (en) Use of sugar compositions
GB0009609D0 (en) Therapeutic compositions
GB0315266D0 (en) Novel galactooligosaccharide composition and the preparation thereof
GB0030857D0 (en) Therapeutic compositions
HUP0301134A3 (en) Use of 7-hydroxyepiandrosterone having neuroprotective activity for preparing pharmaceutical compositions
GB0009607D0 (en) Medical compositions
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2001253219A1 (en) Composition for treatment of autoimmune disease
GB2420709B (en) Skin preparation composition
HUP0400007A2 (en) Use of an alkanoyl-l-carnitine for the preparation of pharmaceutical composition to treat anhedonia